Actuate Therapeutics, Inc.
ACTU
$1.32
-$0.05-3.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.58% | 22.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.01% | 21.70% | |||
| Operating Income | 14.01% | -21.70% | |||
| Income Before Tax | 13.49% | -23.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.49% | -23.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.49% | -23.53% | |||
| EBIT | 14.01% | -21.70% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 14.69% | -23.45% | |||
| Normalized Basic EPS | 14.73% | -23.47% | |||
| EPS Diluted | 14.69% | -23.45% | |||
| Normalized Diluted EPS | 14.73% | -23.47% | |||
| Average Basic Shares Outstanding | 1.42% | 0.04% | |||
| Average Diluted Shares Outstanding | 1.42% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||